PROVECTUS BIOPHARMACEUTICALS, INC. 4
4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Jan 26, 2015
Insider Transaction Report
Form 4
WACHTER ERIC PHD
DirectorVice President Pharmaceuticals
Transactions
- Exercise/Conversion
Common Stock
2015-01-24$1.02/sh+185,000$188,700→ 824,248 total(indirect: By 401(k)) - Exercise/Conversion
Employee Stock Option (right to buy)
2015-01-24−185,000→ 800,000 totalExercise: $1.02From: 2006-06-23Exp: 2016-06-23→ Common Stock (185,000 underlying)
Holdings
- 4,867(indirect: By Trust)
Common Stock
- 5,393,236
Common Stock
Footnotes (1)
- [F1]The Reporting Person's Form 4 filed with the Commission on March 24, 2014 incorrectly reported 639,248 shares of the Issuer's common stock as held directly by the Reporting Person when it should have been reported as indirectly held by the Reporting Person through his 401(k) Plan. This Form 4 accurately reports the number of shares held directly and indirectly by the Reporting Person.